Foyston, Gordon, & Payne’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
VVP
Foyston, Gordon, & Payne's CAH Position: Q2 2017 in Review
Foyston, Gordon, & Payne sold out of Cardinal Health (CAH) in Q2 2017, closing a stake of 18,053 shares — an estimated $1.47M sold.
Foyston, Gordon, & Payne first reported a position in CAH in Q2 2013 and held it in 16 quarters. The position peaked at $30.1M in Q2 2013. 747 funds tracked by Wall St. Rank hold CAH as of Q2 2017.
- Foyston, Gordon, & Payne reported no remaining Cardinal Health position as of Q2 2017 after selling out during the quarter.
- Foyston, Gordon, & Payne sold 18,053 Cardinal Health shares in Q2 2017, an estimated $1.47M.
- Foyston, Gordon, & Payne first reported a position in Cardinal Health in Q2 2013 and held it in 16 quarters.
- Foyston, Gordon, & Payne's Cardinal Health position peaked at $30.1M in Q2 2013.
- 747 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2017.
Based on Foyston, Gordon, & Payne's 13F filing for Q2 2017, filed 14 Aug 2017.